Stambaugh J E, Wainer I W
J Clin Pharmacol. 1981 Apr;21(4):140-6. doi: 10.1002/j.1552-4604.1981.tb05691.x.
To determine the effect of chlorpromazine on the serum concentration-time curve and metabolism of meperidine, 10 healthy volunteers were injected on two separate days in a two-way crossover design with 26 mg/m2 meperidine hydrochloride combined with either 30 mg/m2 chlorpromazine or a placebo. The subjects demonstrated the same serum meperidine concentration-time curves after meperidine plus placebo and meperidine plus chlorpromazine. The excretion of the metabolites normeperidine and normeperidinic acid, however, showed a significant increase with the meperidine-chlorpromazine combination. A marked lethargy was observed after the administration of the meperidine-chlorpromazine combinations in most subjects, which was quite debilitating and may have resulted from the alteration of meperidine metabolism by chlorpromazine. The meperidine-chlorpromazine combination also caused a greater mean depression of the systolic and diastolic pressures than the meperidine-placebo combination. The differences in the blood pressure and symptomatology were significant and represent a potential toxicity that may result from the use of the chlorpromazine-meperidine combination.
为确定氯丙嗪对哌替啶血清浓度 - 时间曲线及代谢的影响,采用双向交叉设计,让10名健康志愿者在两天内分别注射26mg/m²盐酸哌替啶,同时分别联合30mg/m²氯丙嗪或安慰剂。受试者在接受哌替啶加安慰剂及哌替啶加氯丙嗪后,血清哌替啶浓度 - 时间曲线相同。然而,代谢产物去甲哌替啶和去甲哌替啶酸的排泄在哌替啶 - 氯丙嗪联合用药后显著增加。在大多数受试者中,给予哌替啶 - 氯丙嗪联合用药后出现明显嗜睡,这相当虚弱,可能是由于氯丙嗪改变了哌替啶的代谢所致。哌替啶 - 氯丙嗪联合用药比哌替啶 - 安慰剂联合用药导致的收缩压和舒张压平均下降幅度更大。血压和症状学方面的差异具有显著性,代表了使用氯丙嗪 - 哌替啶联合用药可能产生的潜在毒性。